
United Kingdom · Apparel & fashion startup
Vollebak is a British technical clothing brand based in London, founded in 2015 by twin brothers Nick and Steve Tidball.
Funding reportedLast round: Series A
Vollebak is a British technical clothing brand based in London, founded in 2015 by twin brothers Nick and Steve Tidball.
The company focuses on creating innovative apparel designed for extreme conditions, utilizing advanced materials from industries such as aerospace and military research. Vollebak aims to break conventional design rules, emphasizing science and material innovation over seasonal fashion trends. The brand offers a diverse range of high-performance clothing, including jackets, hoodies, and specialized gear. Notable products include the Solar Charged Jacket, Graphene-Enhanced Puffers, and the Apocalypse Clothing line. Vollebak's direct-to-consumer model allows them to maintain quality and control over their brand narrative. They target adventurous and tech-savvy consumers, including ultra-runners, space enthusiasts, and those seeking sustainable fashion solutions. Recognized for their unique designs, Vollebak has won TIME's Best Inventions award twice, solidifying their position as a leader in the technical apparel industry.
Funding, as reported
Vollebak filed 5 raises, $31M in all. Filings say how much was sold and to how many investors; they never name the investors.
What they build
Known for
hardwareintergalactic logisticsconsumersdistributionmanufacturinglightweight materialsspace clothingspace tech collaborationselectromagnetic shieldinggraphene fabricinternet of thingsbacteria-killing fabricsspace technologydisease resistant clothinginformation technology & serviceswearable technology
Built with from their website
HREF LangPaypalKlaviyoGoogle WorkspaceCloudFlareMax Mega MenuViewport MetaGoogle Analytics Ecommerce TrackingGoogle MeetTwilio SendGrid Email Marketing Campaigns
Priority HintsApple PayMobile FriendlyMultilingualShopifyOpen GraphAmazon Route 53Facebook Pixel
Add your raise, your deck and your story, and put Vollebak in front of investors. Or tell us what we have wrong.